enVVeno Medical Corporation (NVNO) Operating income 2017–2025
enVVeno Medical Corporation (NVNO) annual operating income history from SEC filings — each fiscal year as reported.
-$20.9MFY2025 · since FY2017: -$6.1M → -$20.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.9M | +12.3% |
| FY2024 | -$23.8M | +5.6% |
| FY2023 | -$25.2M | -1.2% |
| FY2022 | -$24.9M | -47.6% |
| FY2021 | -$16.9M | -84.9% |
| FY2020 | -$9.1M | -19.0% |
| FY2019 | -$7.7M | +2.3% |
| FY2018 | -$7.9M | -28.7% |
| FY2017 | -$6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVNO financial trends
NVNO RevenueNVNO Net incomeNVNO Net marginNVNO Gross profitNVNO Gross marginNVNO Operating marginNVNO Operating cash flowNVNO Free cash flowNVNO Capital expendituresNVNO Return on equityNVNO Stock buybacksNVNO Dividends paidNVNO Total assetsNVNO Total liabilitiesNVNO Shareholders’ equityNVNO overview →